Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by Surface Enhanced Laser Desorption/Ionization mass spectrometry

Clinical Cancer Research

Volumn 8, Issue 8, 2002, Pages 2541-2552

  Cazares, Lisa H ^a   Adam, Bao Ling ^a   Ward, Michael D ^a   Nasim, Suhail ^a   Schellhammer, Paul F ^a   Semmes, O John ^a   Wright, George L ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; TUMOR PROTEIN; PROTEIN; TUMOR MARKER;

ARTICLE; CALCULATION; CANCER CELL; CELL LYSATE; CHROMOSOME MICRODISSECTION; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; LOGISTIC REGRESSION ANALYSIS; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; ADULT; AGED; HYPERPLASIA; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROTEIN MICROARRAY; STATISTICAL MODEL;

ADULT; AGED; HUMAN; HYPERPLASIA; LOGISTIC MODELS; MALE; MIDDLE AGE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; PROTEIN ARRAY ANALYSIS; PROTEINS; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS, MASS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR MARKERS, BIOLOGICAL; HUMANS; MASS SPECTROMETRY; MIDDLE AGED;

EID: 0036023414     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends
2. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcinoma of the prostate
3. PSA velocity for the diagnosis of early prostate cancer. A new concept
4. PSA, PSA density, PSA density of transition zone, free/total PSA ratio, and PSA velocity for early detection of prostate cancer in men with serum PSA 2.5 to 4.0 ng/ml
5. The role of PSA and percent free PSA for staging and prognosis prediction in clinically localized prostate cancer
6. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in benign prostatic hyperplasia and prostate cancer
7. Precise microdissection of human prostate cancers reveals genotypic heterogeneity
8. Alzheimer's disease
9. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front
10. A unique form of proliferating cell nuclear antigen is present in malignant breast cells
11. Molecular profiling of clinical tissues specimens: Feasibility and applications
12. Gene expression profiles of laser-captured adjacent neuronal subtypes
13. The potential use of laser capture microdissection to selectively obtain distinct populations of cells for proteomic analysis: Preliminary findings
14. Proteomic analysis of laser capture microdissected human prostate cancer and in vitro prostate cell lines
15. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
16. Protein-chip Surface Enhanced Laser Desorption/Ionization (SELDI) mass spectrometry: A novel proteomic technology from detection of prostate cancer biomarkers in complex protein mixtures
17. Differential screening and mass mapping of proteins from premalignant and cancer cell lines using nonporous reversed-phase HPLC coupled with mass spectrometric analysis
18. Protein profiles in sera of patients with malignant cutaneous melanoma
19. Tandem mass spectrometry methods for definitive protein identification in proteomics research
20. Detection and identification of virulence factors in Yersinia pestis using SELDI ProteinChip system
21. Profiling of amyloid β peptide variants using SELDI Protein Chip arrays
22. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine
23. Bactericidal domain of lactoferrin: Detection, quantitation, and characterization of lactoferricin in serum by SELDI affinity mass spectrometry
24. Differential protein profile in the ear-punched tissue of regeneration and non-regeneration strains of mice: A novel approach to explore the candidate genes for soft-tissue regeneration
25. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry
26. Conjugating oligosaccharides to proteins by squaric acid diester chemistry: Rapid monitoring of the progress of conjugation, and recovery of the unused ligand
27. Tissue-specific microdissection coupled with ProteinChip array technologies: Applications in cancer research
28. Laser capture microdissection: Molecular analysis of tissue
29. Molecular mass and carbohydrate structure of prostate specific antigen: Studies for establishment of an international PSA standard
30. New technologies for biomarker analysis of prostate cancer progression: Laser capture microdissection and tissue proteomics
31. Characterization of prostate- specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I
32. The cleavage site specificity of human prostate specific antigen for insulin-like growth factor-binding protein-3
33. Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer
34. Phosphorylation/dephosphorylation of androgen receptor as a determinant of androgen agonistic or antagonistic activity
35. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines
36. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer
37. Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy
38. Molecular forms of prostate-specific antigen in malignant and benign prostatic tissue: Biochemical and diagnostic implications
39. Correlation of serum prostate specific antigen and quantitative immunohistochemistry
40. Tissue PSA from fine-needle biopsies of prostatic carcinoma as related to serum PSA, clinical stage, cytological grade, and DNA ploidy